Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cordaptive in Type 2 Diabetes Mellitus
NCT00485758Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2007
- Primary completion
- Aug 2008
01
Overview
A Phase 3 trial of laropiprant + niacin in dyslipidemia, sponsored by Merck & Co.. Started Jul 2007; status: completed.
02
Drugs
laropiprant + niacin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00485758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485758.